Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups
RegenLife treats Alzheimer’s disease using combined electromagnetic emissions

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

JAD Journal of Alzheimer's Disease

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Share this article